Skip to main content

Table 4 Polysomnographic, MSLT and actigraphic data of four patients with excessive sleepiness after COVID-19 infection

From: Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study

 

Case one

Case two

Case three

Case four

Polysomnographic data

 Total sleep time (h)

350

380

488

462

 Sleep eficiency (%)

87.9

77

94.5

94

 WASO (%)

60

44.5

59.3

20

 Total microarousal index (number/h)

21.9

11.7

21.4

8.4

 Total microarousal

128

97

153

81

 N1 latency (min)/% of sleep

0.2/13.7

66/0.8

5.9/0.4

0/6.4

 N2 latency (min)/% of sleep

17.7/68.3

88/35.3

7.4/49.6

2/57.5

 N3 latency (min)/% of sleep

38/5

102.5/36.7

20.9/25.3

27/53

 AHI total (events/h)

7.7

4.9

9.9

8.7

PLMI total (events/h)

0.8

0

0.1

0.1

Atonia in REM sleep

Y

Y

Y

Y

REM latency (min)/% of sleep

240/13

81/27.2

58/24.7

164/21

MSLT data

 SOREMPs (number)

0

0

2

0

 Mean latency (min)

1.5

5.9

6

Actigraphic data

 Mean total daily sleep time (hours)

11.6

13.2

7

8.4

  1. PSG polysomnographic, RLS restless legs syndrome, WASO wake after sleep onset, N1 NREM 1, N2 NREM 2, N3 NREM 3, AHI apnea hypopnea index, PLMI periodic leg movement index, REM rapid eye movement, MSLT multiple sleep latency test, SOREMP sleep onset REM period, Y yes, N no